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Studies of murine erythropoiesis  in vivo (1, 2)  and of human and murine  marrow 
and blood in vitro have shown that the production of erythrocytes is regulated by an 
orderly  process of maturation  and  terminal  differentiation  of committed  erythroid 
progenitors  presumably  derived  from a  tripotent  hematopoietic  stem  cell  (CFU-S) 1 
(3, 4). 
At least  two classes of committed erythroid progenitors exist  in human blood and 
marrow.  The  most  mature  and  numerous  of these,  the  marrow  erythroid  colony- 
forming unit  (CFU-E)  is an immediate progenitor of the proerythroblast  (3, 5). This 
progenitor rapidly forms single colonies of terminally differentiated erythroid cells in 
vitro under the influence of relatively low concentrations of erythropoietin  and is,  in 
turn, the product of a less-mature progenitor, the erythroid burst-forming unit (BFU- 
E) (3, 5). The behavior of BFU-E in culture is characterized by division and migration 
before arrival at the CFU-E stage and terminal  differentiation. 
More recent  studies  have shown  that  BFU-E are themselves  heterogeneous.  They 
give rise to colonies of varying size, subcolony number, and fetal hemoglobin content 
(6,  7).  Not  surprisingly,  it  ts  believed  that  BFU-E  that  give  rise  to  large  colonies 
capable of gamma-chain expression are less mature than those that give rise to small 
colomes and predominant  hemoglobin A  (7).  Furthermore,  the process of erythropo- 
iesis  is thought to involve a  programmed maturation of immature BFU-E to mature 
BFU-E, during which  time,  enhanced sensitivity  of the progenitor to erythropoietin 
for terminal  differentiation  might occur (7, 8). 
Though BFU-E are largely found in marrow, a  small  fraction of these progenitors 
is detectable in peripheral blood (9,  10) within the null-cell fraction (1 I, 12). However, 
these peripheral  blood progenitors do not exhibit erythropoietin-dependent  differen- 
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tiation  into  typical  hemoglobinized  BFU-E  colonies  in  the  absence  of T  cells  or 
factor(s) derived from appropriately stimulated T  cells (11). A  similar inducer role of 
what has been called lymphocyte mitogenic factor (11), leukocyte conditioned medium 
(4), or burst-promoting activity (8) has been noted in several laboratories. 
One might predict from such observations that a  particular deficiency of T  cells or 
T  celt  function  in  vivo might  be  associated with  erythroid hypoplasia, but  such  a 
complication of immune deficiency has not been regularly reported and, furthermore, 
would only occur if T  cells were additionally required to promote the erythropoietin- 
dependent  differentiation  of  the  mature  BFU-E  that  numerically  dominate  the 
marrow pool of these progenitors. 
To examine the  latter possibility, we have  utilized a  complement-fixing cytolytic 
monoclonal  antibody  that  reacts  with  all circulating T  cells  (13,  14)  to  determine 
whether elimination of whatever peripheral blood T  cells might be present in marrow 
would  depress erythropoietin-dependent differentiation of the  BFU-E  derived from 
that  tissue.  For comparison, we studied the effect of such  antibody-mediated T  cell 
destruction on the differentiation of peripheral blood BFU-E. 
The results show that, in contrast to peripheral blood BFU-E, the vast proportion 
of erythropoietin-dependent marrow BFU-E differentiation in vitro occurs without a 
requirement  for T  cells or T  cell-derived factors  in  the cultures.  This  suggests  that 
during the process of maturation of BFU-E, there is a  loss of T  cell dependence for 
erythropoietin-dependent erythroid differentiation. 
Materials  and  Methods 
Cell Treatment and Culture.  Peripheral blood and bone marrow was obtained from normal 
adult volunteers. Care was taken to aspirate ~2 ml of marrow, the yield of which was ~40 × 
106 ±  10 ×  10  n nucleated cells contaminated wtth ~:3% peripheral T  cells. The clonal assays of 
BFU-E  and  CFU-E  in  human  bone  marrow  and  BFU-E  in  peripheral  blood  have  been 
previously described (9, 15). Briefly, mononuclear cells were isolated by Ficoll (Pharmacia Fine 
Chemicals, Dtv  of Pharmacta, Inc., Piscataway, N  J.) -Hypaque (Winthrop Laboratortes, New 
York)  centrifugation.  Nonadherent  peripheral blood mononuclear cells that  were markedly 
depleted of monocytes  and  B  lymphocytes were  prepared  by  passage  over  nylon  wool  as 
previously described (16).  Highly purtfied T  cells were separated by ammonium chloride lysis 
of pelleted E-rosetting cells. 
A monoclonal cytotoxic IgG antibody reactive with all human circulating T  cells (13,  14) 
was prepared by hybridoma techniques as recently described (17).  We presently refer to this 
antibody as anti-T3. Its activity was established by serial dllutton of the murme ascltes fluid 
into which it was secreted  It was used in all of these studies in a dilution of 1:500 of this fluid 
in minimum essential medium  (S-MEM;  Grand  Island Biological Company, Grand  Island, 
N  Y)  medium  with  10  mM  Hepes  buffer,  to  whtch  5%  fetal  calf serum  (FCS)  (Flow 
Laboratories, Inc, Rockville, Md.) was added. A stmllarly dtluted murine asotes fluid lacking 
monoclonal antibody activity was used as a control. Analysis of mononuclear cell preparations 
for the enumeration of T  cells was performed with a fluorescence-activated cell sorter (FACS) 
(FACS I; Becton Dickinson FACS Systems, Mountain View, Cahf)  (18),  using anti-T3 and a 
fluoreseem-conjugated anti-mouse IgG. 
Treatments of cells with anti-T3 or the control asotes fluid were accomplished by incubation 
of 20  ×  106-40  ×  106 mononuelear cells in  1 ml of the medium  in  which either antibody- 
contaimng, or control, ascites fluid had  been  diluted at  4°C  for 30  mm.  Then,  0  15  ml  of 
freshly frozen rabbit setnam (lot C192108,  Grand Island Biological Company) was added as a 
source of complement  The  incubatton was continued at  37°C  for  1 h  with gentle shaking 
After the incubation at 37°C, the cells were washed three times in a-medmm minus nucleosides 
(a-)  (Grand Island Biological Company)  plus 5%  FCS  The appropriate cell numbers were 
added  in  0.1  ml  of  a--  plus  5%  FCS  to  0.8  ml  of  the  erythropoietin-dependent 352  T  CELL INDUCTION OF  ERYTHROPOIESIS IN MAN 
plasma clot system used by McLeod et al  (15), as modified by Clarke and Housman (9)  There 
were two sources of erythropoietm concentrate  One was a human urinary preparation with a 
28 3  IU/mg protein  sp act  (prepared  by Dr.  Peter  Dukes and  provided by Dr  Anne Ball, 
Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National 
Institutes of Health, Bethesda, Md.). The other was prepared from the plasma of phenylhydra- 
zinc-treated  anemic sheep  (Connaught  Step  III; Connaught  Medical  Research  Laboratory, 
Willowdale, Ontario, Canada), with an -5 IU/mg sp act. Both were used at a final concentra- 
tion in the plasma clot of 2 IU/ml. In some experiments, 0.1  ml of medium in which tetanus 
toxoid-stimulated mononuclear cells had proliferated was substituted for that volume of NCTC- 
109 (Microbiological Associates,  Bethesda, Md.). This medium contains lymphocyte mitogenic 
factor (LMF) (t 1) activity  Clotting was initiated by the addition of 0.1 ml of NCTC-109 that 
contained 1 U of grade I bovine thrombin (Sigma Chemical Company, St  Louis, Mo ). 0.1 ml 
ahquots of the clotting mixture were then  dispersed  in 0.1-microtiter culture wells  (Linbro 
Chemical Co,  Hamden,  Conn.)  and  incubated  in  5% CO2  in  high  humidity  CFU-E were 
enumerated on day 7 and BFU-E on day 11-14 
Data Presentatzon.  All of the' data are expressed as the number of colonies/105 non-T cells 
plated.  This  became  important  only  in  analyses  of peripheral  blood  in  which  substantial 
numbers of T  cells were removed by treatment  with ant~-T3,  but a constant number of cells 
was maintained in the plasma clot  The quantitation of the non-T cell content of mononuclear 
cells was made from the FACS analysts. 
Classzfication of BFU-E  All erythroid colonies with three or more subcolonies were included 
in the total BFU-E count, but a semiquantitative analysis of the size of BFU-E was made from 
morphologic inspection, and the grading system of average BFU-E size  previously described 
(11) was employed to define the appearance of the colonies. 
Results 
FACS Analysts  of Pertpheral  Blood and Marrow Mononuclear Cells.  Fig.  1 A  shows  a 
representative  FACS  analysis  of Ficoll-Hypaque-separated  nonadherent  peripheral 
blood mononuclear cells. In this study, 77% of the mononuclear cells were identified 
as mature  T  cells  by indirect  immunofluorescence with  anti-T3.  Fig.  1 B  shows  the 
FACS analysis of this population after treatment with anti-T3 and complement. It is 
readily  demonstrated  that  the  mature  T  cells  which  comprised  the  majority  of 
peripheral  blood  lymphocytes were  virtually  eliminated  by  this  treatment.  FACS 
analysis of bone marrow mononuclear cells was always quite different.  As shown in 
Fig. 2, a representative analysis, there were virtually no mature T  cells detectable by 
this method in a  Ficoll-Hypaque-separated  sample of marrow mononuclear cells. 
Effect of Treatment of Peripheral Blood Mononuclear Cells wzth Ants-T3 upon BFU-E Colony 
Expresszon.  The  FACS analysis of peripheral  blood  (Fig.  1 A  B)  demonstrated  the 
virtual  elimination  of mature  T  cells  from  the  peripheral  blood  mononuclear  cell 
population  by the antibody and complement treatment.  The effect of this depletion 
on BFU-E colony formation was then studied  in two different  types of experiments, 
examples  of which  are  shown  in  Fig.  3.  In  the  experiment  shown  in  Fig.  3A,  the 
control cells  (treated  with mouse ascites fluid and complement)  were cultured  alone 
and in the presence of varying proportions of LMF in the plasma clot system. BFU-E 
colony formation was not affected morphologically or numerically by this treatment, 
even in the presence of added LMF.  In contrast,  treatment  of the cells with anti-T3 
and complement greatly reduced colony formation, both numerically and with respect 
to colony size,  unless  the cultures  were  fortified  with  as little  as  1%  of the  medium 
that contained LMF activity. 
The experiment  shown in Fig. 3 B was performed differently. Control cells treated 
with mouse ascites fluid and complement developed  BFU-E colonies in culture,  and LIPTON  ET  AL  353 
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Fm  1.  (A)  FACS  analysis of mature T  cell  content  of Ficoll-Hypaque-separated nonadherent 
peripheral blood mononuclear cells  Analysss was done using ants-T3 with a fluorescem-conjugated 
anti-mouse IgG  The area under the curve shows that 77% of the cells were mature T  lymphocytes. 
(B)  A similar FACS analysis of mature T  cell  content of Flcoll-Hypaque separated nonadherent 
pertpheral blood mononuclear cells after treatment with anti-T3 and rabbst complement  There are 
virtually no T  cells remaining in this preparation 
i  ~---~ NEGATIVE  CONTROL 
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Fm  2  FACS  analysis  of  mature  T  cell  content  of  ~'lcoll-[lvpaque-~eparated  bone  marrow 
mononuclear cells  There are virtually no T  cells  m th,s preparation 354  T  CELL INDUCTION OF  ERYTHROPOIESIS IN MAN 
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FIc  3  Influence of anti-T3  and  complement  (Ab +  C')  treatment on  nonadherent  peripheral 
blood mononuclear cell BFU-E colonv expression  In two separate experiments, pertpheral blood 
mononuelear cells were  separated  by  Ficoll-Hypaque centrlfugatlon and  the  nonadherent  cells 
prepared  as  previously described  (14)  The  cells  were  treated  w*th  either  anti-T3  or  with  a 
nommmune murme asc~tes control and cultured m  plasma clot at a concentration of 10  ~ cells/ml m 
the presence of 2 IU erythropoietm  The size of the colomes was graded from  1  + to 4 ÷ as previously 
described (11)  (A) shows the BFU-E growth of control and antibody-treated cells after addJtmn of 
varying amounts of NCTC that contained LMF acnvity  (B) shows the same results after additton 
ofT ceils or 10% LMF to the cultures Cultures ofT cells alone reveal nearly absent colony growth 
growth was enhanced  in  this experiment by added T  cells or LMF, suggesting that 
this sample differed somewhat from the one obtained  for the experiment shown  m 
Fig.  3A in  that  the inducer substance(s)  released by T  cells,  though  present  in  this 
culture,  was  not  at  an  optimal  level.  Treatment  of  the  cells  with  anti-T3  and 
complement greatly reduced  BFU-E  colony formation,  both  numerically and  mor- 
phologically,  and  growth  was  restored  by added  T  cells  and  by  LMF-contalning LIPTON  ET  AL  355 
medium when it was present at  10% of the plasma clot. T  cell preparations themselves 
exhibited virtually no growth of BFU-E colonies, indicating minimal BFU-E contam- 
ination. 
Effect of Treatment of Bone Marrow Mononuclear Cells wzth Antz-T3 and Complement upon 
BFU-E and CFU-E Colony Expresswn.  A  representative  example  of such  a  study  is 
shown in Fig.  4, and the results of several variations of such experiments, including 
the  representative  experiment,  are  shown  in  Table  I.  Fig.  4  demonstrates  that 
treatment with anti-T3 and complement does not reduce marrow CFU-E or BFU-E 
colony growth.  Not  shown is that colony morphology was not affected,  nor was the 
addition ofT cells or 10% LMF influential after antibody and complement treatment 
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Fm  4  Influence of anti-T3 and complement (Ab +  C') treatment of FicolI-Hypaque-separated 
bone marrow mononuclear cells on CFU-E and BFU-E colony expression The different additives 
were LMF at  10% vol/vol and  10  6 T  cells/ml plasma clot culture to control and to ant]-T3 + 
complement-treated cells 
TABLE  I 
Influence of Ant~-  T Cell Antzbody and Complement Treatment on Bone Marrow E~ythroid  Progemtor Colony 
Expresston 
Expertment  1  Expermaent 2  Experiment  3  Expct=mcnt 4 
BFU-E/IO  b  CFU-E/10  ~  BFU-E/10  b  CFU-E/IO  ~  BFU-E/IO  5  CFU-E/IO  5  BFU-E/10  ~  CFU-E/10  ~ 
cells plated  cells plated  cells  plated  cells plated  ~.ells  plated  cells plated  cells plated  ellis plated 
Control 
No addtttve  851"1-123  400±40  447+12  512±53  430±80  230±20  851±132  405±25 
+  LMF*  67 8 ±  4 2  296 ±  105  4q 3 ±  3  1  420 ±  30  --§  --  --  -- 
+  T  cells:~  737±99  525±  I0  3934-50  455-t-30  .... 
Anttbudy +  com- 
plement 
No addmve  907±121  450±50  527±31  480±30  475±65  227 ±  b3  897±140  452±30 
+LMF*  679±38  448±45  573±219  368±22  501±29  260±75  682±43  450 ±  40 
+  T  cells:~  843±48  445±  10  320+  170  285±65  480±  142  193±33  --  -- 
* LMF at  I0~  vol/vol plasma clot (.ulture 
T  ~.t.l[s at  10~'/ml plasma clot culture 
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in the studies in which they were used. In other studies reviewed in the table, LMF or 
T  cells, when added to control cells, were also without effect; indicating that, in our 
hands at least, the culture system is usually optimal with respect to whatever LMF or 
T  cell products may be required for the expression of CFU-E and BFU-E colonies in 
vitro. 
Discussion 
The results of these studies clearly demonstrate that  in vitro requirements for the 
terminal differentiation of mature human  marrow BFU-E differ substantially from 
the requirements for differentiation of the peripheral blood BFU-E. The addition of 
T  cells, or their products, is not necessary to induce marrow BFU-E differentiation, 
whereas one or the other is required for optimal differentiation of peripheral blood 
BFU-E. 
The requirement for T  cells or their products for peripheral blood BFU-E differ- 
entiation  (11)  was  previously  examined  in  studies  in  which  the  progenitor-rich 
mononuclear cell population was physically separated from accompanying B and T 
lymphocytes (19). The role ofT cells as inducers oferythropoietin-dependent erythroid 
burst  formation in  null  cells was  then  observed. At  approximately the same  time, 
several laboratories reported requirements for conditioned media in which T  cells had 
proliferated in  response  to  mitogens  for optimal  human  and  murine  marrow  and 
blood BFU-E colony formation (4, 8, 20, 21). 
One of the most  interesting of these studies is  that  of Eaves and  Eaves  (4), who 
utilized the methylcellulose culture system to analyze the differentiation of marrow 
BFU-E into erythroid colonies. That culture system permits the continuous observa- 
tion of the accrual of newly forming colonies, each of which require varying periods 
of growth to obtain maximal size and  hemoglobin accumulation.  Eaves and  Eaves 
found that  such  mitogen-stimulated  conditioned media  were only required for the 
optimal differentiation of what appeared to be the most primitive BFU-E in marrow 
culture  (4),  progenitors  that  constitute  only  ~15%  of the  total  marrow  BFU-E 
population (22). These observations lead to the logical conclusion that marrow BFU- 
E  represent a  very heterogeneous population of cells of varying maturity, and  that 
peripheral blood BFU-E might  represent  a  relatively immature subset  of the total 
BFU-E population. Indeed, the bulk of marrow BFU-E have been found to differ in 
several respects from peripheral blood BFU-E.  In addition  to their differences in T 
cell  requirements  for differentiation  in  culture,  peripheral  blood  BFU-E  represent 
only ~ 1% of the total marrow and blood BFU-E population (23). In our hands, their 
development into colonies requires higher concentrations of crude erythropoietin in 
the plasma clot culture system than does the development of the majority of marrow 
progenitors  (24).  A smaller proportion of peripheral  blood BFU-E than of marrow 
BFU-E are m  the process of DNA synthesis (25). Finally, hemoglobin F synthesis is 
easily  demonstrable  m  almost  all  of the  colonies  derived  from  the  growth  and 
differentiation of peripheral blood BFU-E  (26-28), whereas hemoglobin F synthesis 
is relatively lower (28) and often difficult to demonstrate (26) in plasma clot cultures 
derived  from  completely normal  human  subjects  All  of the  differences described 
above support the impression that peripheral blood BFU-E represent a subset of the 
BFU-E population that  is less mature, i e., closer in development to CFU-S, than is 
the bulk of the marrow BFU-E population  It is this relatively primitive progenitor LIPTON ET AL  357 
population that  appears  to require a  product  that  can  be derived from T  cells to 
induce the interaction of the progenitor with erythropoietin and to permit differen- 
tiation into colonies. 
It  must  be  emphasized,  however,  that  the  studies  of marrow  BFU-E  colony 
formation reported here and  elsewhere provide insight  only into differentiation of 
these  BFU-E  into  erythroid  colonies  and  not  into  their  replication.  The  role  of 
erythropoietin in erythroid-progenitor development has been explored by Udupa and 
Reissman  (1). They clearly demonstrated that the replication of mature BFU-E and 
CFU-E  is  highly erythropoietin responsive, whereas  the development of immature 
BFU-E from CFU-S  and  their replication is  much  less,  if at  all,  responsive to the 
hormone  Amplification of erythropoiesis occurs as BFU-E mature and replicate in 
response to ambient erythropoietin. 
Thus, we conclude that  primitive BFU-E are initially derived from CFU-S  by a 
stochastic maturation process. These early-committed progenitors replicate very slowly 
and progressively mature.  During that  maturation process, they develop increasing 
sensitivity to erythropoietin such that at ambient levels of the hormone, they replicate 
more rapidly and amplify the system. When maturing and replicating, BFU-E acquire 
still more erythropoietin sensitivity, they finally differentiate to form CFU-E and then 
adult erythrocytes. These adult erythrocytes contain  100% hemoglobin A  (A eryth- 
rocytes) and  comprise ~95% of the circulating erythrocytes in  normal  individuals. 
Mature T  cells or their products are not involved in this process of differentiation. In 
contrast, the differentiation of primitive BFU-E into F erythrocytes (erythrocytes that 
contain hemoglobin F and A), a process that is enhanced during stress erythropoiesis 
(29), requires induction by T  cells or their products as an adjunct  to high levels of 
erythropoietin. T  cells undetectable by these methods or T  cell precursors may fulfill 
this role in vivo. 
Examination of erythropoiesis in severe combined immunodeficiency (SCID) pro- 
vides  only  a  limited  opportunity  to  evaluate  the  physiological  relevance  of this 
concept. Patients with SCID have prothymocytes and early thymic precursors that 
mature abnormally or not at all. The T  cells of these patients as such do not promote 
lymphoid differentiation  (30,  31).  Because the  differentiation of mature  BFU-E  to 
erythrocytes does not require T  cells or their products, basal erythropoiesis should be 
evident  in  these  patients.  In  fact,  most  of them  are  not  more  anemic  than  their 
burdens of infection would produce. One might expect, however, that stress erythro- 
poiesis and the production of F erythrocytes would be limited in such patients unless 
the immature thymocytes present in their marrow secrete the inducer factors that act 
as adjuncts to immature BFU-E differentiation. Unfortunately, the age most of these 
patients and the concomitant expression of fetal hemoglobin synthesis interfere with 
the assessment in them of F erythrocyte production as an index of stress erythropoiesis. 
A  pressing  biological  question  raised  by  these  and  other  studies  concerns  the 
chemical basis ofT cell induction of antibody synthesis (32, 33), eosinophil production 
(34), and T  cell proliferation, to say nothing of erythroid differentiation. With respect 
to the erythroid system, the understanding of this molecular biology awaits purifica- 
tion of sufficient quantities of labeled functional erythropoietin and isolation of the 
progenitor cell  itself so that  the  interaction of the  hormone with  its  target  can  be 
studied in reasonably homogeneous systems. In recent work (35), a  subset of T  cells 
defined  by  a  monoclonal  hybridoma  antibody,  anti-T4,  has  been  found  to  be 358  T  CELL INDUCTION OF ERYTHROPOIESIS IN MAN 
responsible  for  LMF  production.  This  same  subset  of cells  is  required  for  B  cell 
proliferation and differentiation,  secretion of immunoglobulins, as well as generation 
of cytotoxic T  cells  (36-38).  Further investigation  into the T  cell subsets responsible 
for induction of erythropoietm-dependent  erythroid differentiation  will more specifi- 
cally identify the inducer cell in that system. 
Summary 
Cell-cell interactions between mature T  cells and peripheral blood null cells reduce 
erythropoietin-stimulated  differentiation  of peripheral  blood-derived  erythroid  pro- 
genitors.  By the  use  of a  complement-fixing cytolytic murine  hybridoma  antibody 
uniquely reactive with mature T  lymphocytes, this dependence of immature periph- 
eral blood erythroid burst-forming unit  (BFU-E) differentiation upon mature T  cells 
or  a  T  cell  conditioned  medium  is  confirmed.  By  using  the  same  antibody,  it  is 
demonstrated that the differentiation of mature bone marrow BFU-E does not require 
either mature T  cells or lymphocyte mitogenic factor. These findings do not preclude 
the presence in the bone marrow of other cells, perhaps even immature T  cells, that 
influence erythropoietin-dependent  erythroid differentiation of mature marrow BFU- 
E. 
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